Lifeforce Capital

Lifeforce Capital is a venture capital firm founded in 2015 that invests in software companies operating in healthcare markets. Its stated thesis centres on businesses reshaping the status quo in healthcare's largest markets, spanning two principal areas: new technologies and care models advancing care delivery, and software-first computational drug discovery platforms. The firm lists healthcare software, care delivery technology and computational drug discovery among its technical domains, with portfolio exposure across healthcare technology, biotechnology and pharmaceutical drug discovery.

The firm is founder-led, with John Noonan serving as founder and managing partner, and is reported to have a team of 1–10 employees. Its geographic presence is in the United States. Information on stage, check size and fund structure is not disclosed in the materials reviewed; the firm's public website carries details on its portfolio and exits.

For candidates, the relevant context is the concentration of the mandate. Healthcare software investing has broadened over the past decade to include both care delivery businesses and computational approaches to drug discovery, and Lifeforce Capital operates at that intersection rather than across technology sectors generally.